Synthesis of novel 2-[4-(4-substitutedbenzamido/phenylacetamido) phenyl]benzothiazoles as antimicrobial agents

Medicinal Chemistry Research

Volumn 21, Issue 11, 2012, Pages 3818-3825

  Bolelli, Kayhan ^a   Yalcin, Ismail ^a   Ertan Bolelli, Tugba ^a   Özgen, Selda ^b   Kaynak Onurdag, Fatma ^a,b   Yildiz, Ilkay ^a,b   Aki, Esin ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Antibacterial activity; Antifungal activity; Benzothiazole; Multi drug resistance

Indexed keywords

2 [4 (4 BROMOBENZAMIDO)PHENYL]BENZOTHIAZOLE; 2 [4 (4 BROMOPHENYLACETAMIDO)PHENYL]BENZOTHIAZOLE; 2 [4 (4 CHLOROBENZAMIDO)PHENYL]BENZOTHIAZOLE; 2 [4 (4 CHLOROPHENYLACETAMIDO)PHENYL]BENZOTHIAZOLE; 2 [4 (4 ETHYLBENZAMIDO)PHENYL]BENZOTHIAZOLE; 2 [4 (4 FLUOROBENZAMIDO)PHENYL]BENZOTHIAZOLE; 2 [4 (4 FLUOROPHENYLACETAMIDO)PHENYL]BENZOTHIAZOLE; 2 [4 (4 METHOXYPHENYLACETAMIDO)PHENYL]BENZOTHIAZOLE; 2 [4 (4 METHYLPHENYLACETAMIDO)PHENYL]BENZOTHIAZOLE; 2 [4 (4 NITROBENZAMIDO)PHENYL]BENZOTHIAZOLE; 2 [4 (4 TERT BUTYLBENZAMIDO)PHENYL]BENZOTHIAZOLE; AMPHOTERICIN B; AMPICILLIN; ANTIINFECTIVE AGENT; BENZOTHIAZOLE DERIVATIVE; FLUCONAZOLE; GENTAMICIN; OFLOXACIN; RIFAMPICIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIUM ISOLATE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; FUNGUS ISOLATION; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84871431899     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9918-4     Document Type: Article

References (25)

1. Ager IR, Barnes AC, Danswan GW, Hairsine PW, Kay DP, Kennewell PD, Matharu SS, Miller P, Robson P, Rowlands DA, Tully WR, Westwood R (1988) Synthesis and oral antiallergic activity of carboxylic acids derived from imidazo[2,1-c][1,4]benzoxazines, imidazo[1,2-A]quinolines, imidazo[1,2-A] quinoxalines, imidazo [1,2-A]quinoxalinones, pyrrolo[1,2-A]quinoxalinones, pyrrolo[2,3-A]quinoxalinones, and imidazo[2,1-b]benzothiazoles. J Med Chem 31:1098-1115
2. Chua M, Shi D, Wrigley S, Bradshaw TD, Hutchinson I, Shaw PN, Barrett DA, Stanley LA, Stevens MFG (1999) Antitumour benzothiazoles. 7. Synthesis of 2-(4-Acylaminophenyl)benzothiazoles and investigations into the role of acetylation in the antitumour activities of the parent amines. J Med Chem 42:381-392
3. Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS) (2006a) Performance standards for antimicrobial disk susceptibility tests, approved standard, M2-A9, Clinical and Laboratory Standards Institute, 940 West Valley Road, Wayne, PA Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS) (2006b) Performance standards for antimicrobial susceptibility testing, 16th informational supplement. CLSI M100-S16, Clinical and Laboratory Standards Institute, 940
4. West Valley Road, Wayne, PA Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS) (2006c) Reference method for broth dilution antifungal susceptibility testing yeast, approved standard, M27-A3, Clinical and Laboratory Standards Institute, 940 West Valley Road
5. Wayne, PA Dilworth JR, Peach JM, Heslop JM, Donnelly PS (2007) Preparation of transition metal thiosemicarbazone derivative complexes for medical imaging and therapy. World Intellectual Property Organization, WO2007003944 A2
6. Fridkin SK, Gaynes RP (1999) Antimicrobial resistance in intensive care units. Clin Chest Med 20(2):303-316
7. Hein DW, Alheim RJ, Leavitt JJ (1957) The use of polyphosphoric acid in the synthesis of 2-Aryl and 2-Arkyl substituted benzimidazoles, benzoxazoles and benzothiazoles. J Am Chem Soc 79(2):427-429
8. Hutchinson I, Jennings SA, Vishnuvajjala BR, Westwell AD, Stevens MFG (2002) Antitumour benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumour 2-(4-Aminophenyl)benzothiazole amino acid prodrugs. J Med Chem 45:744-747
9. Kagaya T, Kajiwara A, Nagato S, Akasaka K, Kubota A (1996) E2011 A novel, selective and reversible inhibitor of monoamine oxidase type A. J Pharmacol Exp Ther 278:243-251
10. Kalina PH, Shetlar DJ, Lewis RA, Kullerstrand LJ, Brubaker RF (1988) 6-Amino-2-benzothiazole-sulfonamide. The effect of a topical carbonic anhydrase inhibitor on aqueous humor. Ophthalmology 95:772-777
11. Katz L (1953) Antituberculous compounds. III. Benzothiazole and benzoxazole derivatives. Contribution from the Schenley Laboratory 75:712-714
12. Koc J, Klimesova V, Waisser K, Kaustova J, Dahse HM, Mollmann U (2002) Heterocyclic benzazole derivatives with antimycobacterial in vivo activity. Bioorg Med Chem Lett 12:3275-3278
13. Komatsu Y, Minami N (1995) Synthesis of a novel dual inhibitor of thromboxane A2 synthetase and 5-lipoxygenase (E3040) via the direct coupling reaction of hydroquinone with 3-pyridinecarboxaldehyde. Chem Pharm Bull 43:1614-1616
14. Kuçukbay H, Durmaz B (1997) Antifungal activity of organic and organometallic derivatives of benzimidazole and benzothiazole. Drug Res 47:667-670
15. Paramashivappa R, Phani Kumar P, Subba Rao PV, Srinivasa Rao A (2003) Synthesis and anti-HIV-1 inhibition of novel benzimidazole derivatives. Bioorg Med Chem Lett 13:657-660
16. Pinar A, Yurdakul P, Yildiz-Oren I, Temiz-Arpaci O, Acan NL, Aki-Sener E, Yalcin I (2004) Some fused heterocyclic compounds as eukaryotic topoisomerase II inhibitors. Biochem Biophys Res Commun 317(2):670-674
17. Shi DF, Bradshaw TD, Wrigley S, McCall CJ, Lelieveld P, Fichtner I, Stevens MFG (1996) Antitumor benzothiazoles. Part 3. Synthesis of 2-(4-Aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. J Med Chem 39:3375-3384
18. Stevens MFG, McCall JC, Lelieveld P (1995) Benzazole compounds for use in therapy. World Intellectual Property Organization, WO9506469
19. Surin J (1995) Anti-nematode activity of sixteen compounds against Trichinella spiralis in mice -A possible new screen for macrofilaricides. Southeast Asian J Trop Med Public Health 26(1): 128-134
20. Tekiner-Gulbas B, Temiz-Arpaci O, Yildiz I, Aki-Sener E, Yalcin I (2006) 3D-QSAR study on heterocyclic topoisomerase II inhibitors using CoMSIA. SAR QSAR Environ Res 17(2): 121-132
21. Temiz-Arpaci O, Tekiner-Gulbas B, Yildiz I, Aki-Sener E, Yalcin I (2005) 3D-QSAR analysis on benzazole derivatives as eukaryotic topoisomerase II inhibitors by using comparative molecular field analysis method. Bioorg Med Chem 13:6354-6359
22. Trapani G, Latrofa A, Franco M, Armenise D, Morlacchi F, Liso G (1994) Synthesis and antimicrobial activity of some N-Alkenyl-2-Acylalkylidene-2,3- dihydro-1,3-benzothiazoles. Arzneim Forsch 44(8):969-971
23. Yalçin I, O ren I, Ş ener E, Akin A, Uçarturk N (1992) The synthesis and the structure-Activity relationships of some substituted benzoxazoles, oxazolo(4,5-b)pyridines, benzothiazoles and benzimidazoles as antimicrobial agents. Eur J Med Chem 27: 401-406
24. Yalçin I, Kocyigit-Kaymakcioglu B, Oren I, Sener E, Temiz O, Akin A, Altanlar N (1997) Synthesis and microbiological activity of some novel N-(2-hydroxyl-5-substitutedphenyl)benzacetamides, phenoxyacetamides and thiophenoxyacetamides as the possible metabolites of antimicrobial active benzoxazoles. Il Farmaco 52(11):685-689
25. Yildiz-Oren I, Yalcin I, Aki-Sener E, Uçarturk N (2004) Synthesis and structure-Activity relationships of new antimicrobial active multisubstituted benzazole derivatives. Eur J Med Chem 39: 291-298